Insider plans sale of 2,089 common shares

TFSL insider Meredith S. Weil has filed a notice of intent to sell 2,089 shares of common stock, with an aggregate market value of $31,606.00.

Accepted by SEC EDGAR 02/10/2026 - 03:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TFSL insider Meredith S. Weil has filed a notice of intent to sell 2,089 shares of common stock, with an aggregate market value of $31,606.00. The planned sale is to be executed through Charles Schwab on the NASDAQ around 02/10/2026, against total common shares outstanding of 280,570,799.

The 2,089 shares were acquired on 08/15/2017 as a restricted stock unit grant from the issuer, classified as equity compensation. During the past three months, Weil previously sold 15,000 common shares on 11/12/2025 for gross proceeds of $207,784.13, as disclosed in the filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TFSL shares does Meredith S. Weil plan to sell under this Form 144?

Meredith S. Weil plans to sell 2,089 shares of TFSL common stock. The filing lists an aggregate market value of $31,606.00 for this block, with the transaction expected to occur on or about 02/10/2026 on the NASDAQ market.

What is the market value of the TFSL shares Meredith S. Weil intends to sell?

The planned sale by Meredith S. Weil covers shares with an aggregate market value of $31,606.00. This value is based on the 2,089 TFSL common shares disclosed, which are expected to be sold through Charles Schwab on the NASDAQ exchange around 02/10/2026.

How and when did Meredith S. Weil acquire the TFSL shares being sold?

The 2,089 TFSL common shares were acquired on 08/15/2017 through a restricted stock unit grant from the issuer. The filing classifies this as equity compensation, with the acquisition and payment date both listed as 08/15/2017.

What TFSL share sales has Meredith S. Weil made in the last three months?

In the past three months, Meredith S. Weil sold 15,000 TFSL common shares on 11/12/2025. The filing reports $207,784.13 in gross proceeds from this earlier transaction, separate from the newly planned 2,089-share sale disclosed in the current notice.

How many TFSL common shares are outstanding according to this filing?

The filing reports 280,570,799 TFSL common shares outstanding. This figure provides context for the planned sale of 2,089 shares by Meredith S. Weil and the prior 15,000-share sale disclosed for the last three months.

Through which broker and exchange will the TFSL shares be sold?

The planned 2,089-share sale is to be executed through Charles Schwab Corporation, located in Westlake, Texas. The filing specifies that the TFSL common stock is to be sold on the NASDAQ securities exchange, with an approximate sale date of 02/10/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001530997
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TFS Financial CORP
SEC File Number	001-33390
Address of Issuer	7007 BROADWAY AVENUE CLEVELAND OHIO 44105
Phone	(216) 441-6000
Name of Person for Whose Account the Securities are To Be Sold	WEIL MEREDITH S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corporation 3000 Schwab Way Westlake TX 76262	2089	31606.00	280570799	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2017	Restricted Stock Unit	Issuer			2089	08/15/2017	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Meredith S. Weil 7007 BROADWAY AVENUE, Cleveland OH 44105	Common	11/12/2025	15000	207784.13

144: Remarks and Signature

Remarks	Meredith S. Weil trustee Michael R Weil Jr. Rev. Trust, Meredith S Weil Rev Trust Held as TIC
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Meredith S. Weil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)